Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04635696 · ClinicalTrials.gov registry record · Phase 4
Ethyl Chloride for NPWT
A Phase 4 study, sponsored by ProMedica Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT04635696 is a Phase 4 study that has completed, run by ProMedica Health System. The registered enrollment target is 100 participants.
The verdict
NCT04635696, a Phase 4 study, has completed, sponsored by ProMedica Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
Negative pressure wound therapy (NPWT) has been shown to improve wound care outcomes for acute and chronic wounds as well as for surgical incision sites. We have found that patients report significant pain during dressing changes specifically with the removal of the clear adhesive drape. Upon review of the literature, there were multiple studies related to pain and the removal of the sponge (filler) but limited studies relating to the pain associated with the removal of the drape. The patient reported pain with drape removal has led to increased psychological stress and decreased compliance with the dressing change protocol. Application of a topical anesthetic to the drape during the dressing change has the potential to decrease the pain experienced by the patient. An FDA approved ethyl chloride spray is a topical anesthetic that can be sprayed onto the outer perimeter of the drape during the dressing change as a means to decrease pain. We hypothesize that the use of ethyl chloride spray will result in patients experiencing less pain leading to decreased psychological stress, improved compliance with dressing changes, and overall improved customer satisfaction.
Interventions
- DRUG Ethyl chloride
- OTHER Tissue culture grade water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-01-07 |
| Est. Completion | 2020-12-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04635696
The ClinicalTrials.gov registry entry for NCT04635696 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ProMedica Health System, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ethyl chloride is the first listed.
NCT04635696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04635696 about?
NCT04635696 is a clinical study titled "Ethyl Chloride for NPWT". Negative pressure wound therapy (NPWT) has been shown to improve wound care outcomes for acute and chronic wounds as well as for surgical incision sites. We have found that patients report significant pain during dressing changes specifically with the removal of the clear adhesive drape. Upon review...
What is the current status of trial NCT04635696?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2019-01-07. Estimated completion is 2020-12-10.
What interventions are being tested in trial NCT04635696?
The interventions under investigation include: Ethyl chloride (DRUG), Tissue culture grade water (OTHER).
Who is sponsoring clinical trial NCT04635696?
This trial is sponsored by ProMedica Health System, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.